Stay updated on Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T19:27:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has updated to version v2.14.0, adding fields for 'Type of intervention' and 'Principal Investigator', while removing the previous version's 'type of intervention'.
    Difference
    0.6%
    Check dated 2025-01-13T11:50:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-15T19:52:32.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-08T17:06:16.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    The phrase 'This study has 1 location' has been added, while the version with a comma has been removed.
    Difference
    0.4%
    Check dated 2024-12-01T16:33:15.000Z thumbnail image
  9. Check
    63 days ago
    Change Detected
    Summary
    The website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.
    Difference
    4%
    Check dated 2024-11-23T04:39:19.000Z thumbnail image

Stay in the know with updates to Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.